Search All News
In people with dementia, delirium during COVID-19 is more common but deaths from COVID-19 are not disproportionately higher, finds a new study.
New research may lead to the development of drugs to prevent the nerve damage and pain many cancer patients experience during chemotherapy.
Cells used to study the human blood-brain barrier in the lab aren’t what they seem, a new study has found, throwing nearly a decade’s worth of research into question.
A new Columbia study suggests that malfunctioning endosomes—a central trafficking station inside neurons—are commonly involved in the appearance of Alzheimer’s disease.
- November 14, 2019
A new study finds that cognitive impairment begins in the earliest stages of age-related hearing loss—when hearing is still considered normal.
- November 1, 2019
A new study from Columbia University found that a higher level of education protected against cognitive decline in black people with a gene linked to Alzheimer’s disease.
- October 21, 2019
A new study suggests that many different immune cells, not just T cells, are involved in triggering multiple sclerosis (MS).
- October 2, 2019
Only select neurons die during Parkinson’s disease. Columbia researchers are looking for clues in immune cells to find out what makes these brain cells so vulnerable.
- August 15, 2019
With several targeted Parkinson’s disease drugs entering clinical trials, a new genetic testing and counseling program may help identify patients who qualify for enrollment.
- March 20, 2019
Survivors of cardiac arrest are more likely to experience further heart trouble if they have symptoms of PTSD, according to a new study from researchers at Columbia University Irving Medical Center.
- January 31, 2019
Aerobic exercise is known to improve cognition in the elderly; a new Columbia study shows it’s good for adults as young as 20.